Revised guidelines for the control of methicillin-resistant Staphylococcus aureus infection in hospitals

Journal of Hospital Infection

Volumn 39, Issue 4, 1998, Pages 253-290

  Ayliffe, G A J ^a   Buckles, A ^b   Casewell, M W ^c   Cookson, B D ^d   Cox, R A ^e   Duckworth, G J ^f,m   French, G L ^c   Griffiths Jones, A ^g   Heathcock, R ^h   Humphreys, H ⁱ   Keane, C T ^j   Marples, R R ^d   Shanson, D C ^k   Slack, R ^l   Tebbs, E ^h  

^a CITY HOSPITAL   (United Kingdom)

^b ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d CENTRAL PUBLIC HEALTH LABORATORY   (United Kingdom)

^e KETTERING GENERAL HOSPITAL   (United Kingdom)

^f QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^g ROYAL GWENT HOSPITAL   (United Kingdom)

^h Royal Gwent Hospital ^*

ⁱ NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^j ST JAMES S HOSPITAL   (Ireland)

^k Unilabs   (France)

^l Nottingham Health Authority   (United Kingdom)

^m CDSC (Thames)   (United Kingdom)

more..

Author keywords

Guidelines; Hospital infection; Infection control; Methicillin resistant Staphylococcus aureus; MRSA

Indexed keywords

HOSPITAL INFECTION; INFECTION CONTROL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PRACTICE GUIDELINE; REVIEW;

EID: 0842338939     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0195-6701(98)90293-6     Document Type: Review

References (135)

1. Report of a combined working party of the Hospital Infection Society and British Society for Antimicrobial Chemotherapy. Guidelines for the control of methicillin-resistant Staphylococcus aureus. J Hosp Infect 1986; 7: 193-201.
2. Working party report. Guidelines for the control of epidemic methicillin-resistant Staphylococcus aureus. J Hosp Infect 1990; 16: 351-377.
3. Shanson DC. Antibiotic-resistant Staphylococcus aureus. J Hosp Infect 1981; 2: 11-36.
4. Report of a combined Working Party of the British Society for Antimicrobial Chemotherapy and the Hospital Infection Society. Guidelines on the control of methicillin-resistant Staphylococcus aureus in the community. J Hosp Infect 1995; 31: 1-12.
5. Epidemic methicillin-resistant Staphylococcus aureus. CDR 1995; 5: 35.
6. Hodgson JE, Curnock SP, Dyke KGH et al. Molecular characterization of the gene encoding high-level mupirocin resistance in Staphylococcus aureus J2870. Antimicrob Agents Chemother 1994; 38: 1205-1208.
7. Cookson BD. Mupirocin resistance in staphylococci. J Antimicrob Chemother 1990; 25: 497-501.
8. Lacey RW. Multi-resistant Staphylococcus aureus - a suitable case for inactivity? J Hosp Infect 1987; 9: 103-105.
9. Barratt SP, Teare EL, Sage R. Methicillin-resistant Staphylococcus aureus in three adjacent health districts of south-east England 1986-1991. J Hosp Infect 1993; 24: 313-325.
10. Farrington M, Ling G, Ling T, French GL. Outbreaks of infection with methicillin-resistant Staphylococcus aureus on neonatal and burns units of a new hospital. Epidemiol Infect 1990; 105: 215-228.
11. Hartstein AI. Improved understanding and control of nosocomial methicillin-resistant Staphylococcus aureus: are we overdoing it? Infect Control Hosp Epidemiol 1995; 16: 257-259.
12. Cafferkey MT, Hone R, Keane CT. Sources and outcome for methicillin-resistant Staphylococcus aureus bacteraemia. J Hosp Infect 1988; 11: 136-143.
13. Romero-Vivas J, Rubio M. Fernandez C, Picazo JJ. Mortality associated with nosocomial bacteraemia due to methicillin-resistant Staphylococcus aureus. Clin Infect Dis 1995; 21: 1417-1423.
14. Maslow JN, Brecher S, Gunn J et al. Variation and persistence of methicillin-resistant Staphylococcus aureus strains among individual patients over extended periods of time. Eur J Clin Microbiol Infect Dis 1995; 14: 282-290.
15. Coello R, Glynn JR, Gaspar C, Picazo JJ, Fereres J. Risk factors for developing clinical infection with methicillin-resistant Staphylococcus aureus (MRSA) amongst hospital patients initially only colonized with MRSA. J Hosp Infect 1997; 37: 39-46.
16. Humphreys H. Comparison of infections caused by methicillin- sensitive and methicillin-resistant Staphylococcus aureus. In: Cafferkey MT, Ed. Methicillin-resistant Staphylococcus aureus. Clinical management and laboratory aspects. New York: Marcel Deckker 1992; 77-90.
17. Keane CT, Coleman DC, Cafferkey MT. Methicillin-resistant Staphylococcus aureus - a reappraisal J Hosp Infect 1991; 19: 147-152.
18. Rello J, Torres A, Ricart M et al. Ventilator-associated pneumonia by Staphylococcus aureus: comparison of methicillin-resistant and methicillin-sensitive episodes. Am J Respir Crit Care Med 1994; 150: 1545-911.
19. Peacock JE, Marsik FJ, Wenzel RP. Methicillin-resistant Staphylococcus aureus: introduction and spread within a hospital. Ann Intern Med 1980; 93: 526-532.
20. Hunt JL, Purdue GL, Tuggle DW. Morbidity and mortality of an endemic pathogen: methicillin-resistant Staphylococcus aureus. Am J Surg 1988; 156: 524-527.
21. Boyce JM, Landrey M, Deetz TR, Dupont HL. Epidemiologic studies of an outbreak of nosocomial methicillin-resistant Staphylococcus aureus infections. Infection Control 1981; 2; 110-116.
22. French G, Cheng AFB, Ling JML, Mo P, Donnan S. Hong Kong strains of methicillin-resistant and methicillin-sensitive Staphylococcus aureus have similar virulence. J Hosp Infect 1990; 15: 117-125.
23. Cookson BD, Morrison D, Marples RR. Nosocomial gram positive infection. J Med Microbiol 1997; 6: 439-442.
24. Speller DCE, Johnson AP, James D et al. Resistance to methicillin and other antibiotics in isolates of Staphylococcus aureus from blood and cerebrospinal fluid, England and Wales, 1989-95. Lancet 1997; 350: 323-325.
25. Gransden WR, Atkinson D, Stead KC, Phillips I. Antibiotic resistance of Staphylococcus aureus 1969-1981. In: Proceedings of the 13th International Congress of Chemotherapy Vienna, 1983; 8, 7.27. 2-11.
26. Cookson BD, Phillips I. Epidemic methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 1988; Suppl.C: 57-65.
27. Casewell MW. Cost-effectiveness of topical antibiotics and antiseptics for the control of MRSA. In: Bruin-Buisson C, Casewell MW, El Solh N, Régnier B, Eds. Methicillin resistant staphylococci. Paris, Médecine-Sciences 1995: 141-148.
28. Vandenbroucke-Grauls CM. Control of methicillin-resistant Staphylococcus aureus in the Netherlands. In: Coello R, Casewell MW, Eds. Methicillin-resistant Staphylococcus aureus. Kent, UK: Wells Medical Limited 1993: 75-78.
29. Cox RA, Conquest C, Mallaghan C, Marples RR. Major outbreak of methicillin-resistant Staphylococcus aureus caused by a new phage type (EMRSA-16). J Hosp Infect 1995; 29: 87-106.
30. Bendall RP, Gonzalez-Ruiz, Baptiste L, Kelsey MC. Outcome of methicillin-resistant Staphylococcus aureus carriage. Lancet 1994; 344: 819.
31. Kerr S. Kerr GE, Mackintosh CA, Marples RR. A survey of methicillin resistant Staphylococcus aureus affecting patients in England and Wales. J Hosp Infect 1990; 16: 35-48.
32. Coello R, Glenister H, Feres J, Cooke EM. The cost of infection in surgical patients: a case control study. J Hosp Infect 1993; 25: 239-250.
33. Mehtar S, Drabu YJ, Mayet F. Expenses occurred during a 5-week epidemic of methicillin-resistant Staphylococcus aureus. J Hosp Infect 1989; 13: 199-220.
34. Coello R, Jiménez J, Garcia M et al. Prospective study of infection, colonisation and carriage of methicillin-resistant Staphylococcus aureus affecting 900 patients. Eur J Clin Microbiol Infect Dis 1994; 13: 74-81.
35. Palau E. Implications of methicillin-resistant Staphylococcus aureus for hospital management and public relations. In: Coello R, Casewell MW, Eds. Methicillin-resistant Staphylococcus aureus. Kent, UK: Wells Medical Ltd 1993: 67-70.
36. Riley TV, Carson CF, Bowman RA et al. Mupirocin-resistant methicillin-resistant Staphylococcus aureus in Western Australia. Med J Australia 1994; 161: 397-398.
37. Rosdahl VT, Knudsen AM, The decline of methicillin resistance among Danish Staphylococcus aureus strains. Infect Control Hosp Epidemiol 1991; 12: 83-88.
38. Coello R, Fernández C, Arroyo P et al. Success and failure in the control of methicillin-resistant Staphylococcus aureus. In: Coello R, Casewell MW, Eds. Methicillin-resistant Staphylococcus aureus. Kent, UK: Wells Medical Limited, 1993: 95-98.
39. Hartstein AI, Denny MA, Morthland VH, LeMonte AM. Control of methicillin-resistant Staphylococcus aureus in a hospital and an intensive care unit. Infect Control Hosp Epidemiol 1995; 16: 405-411.
40. Casewell MW. New threats to the control of methicillin-resistant Staphylococcus aureus. J Hosp Infect 1995; 30 (Suppl): 465-471.
41. Blumberg LH, Klugman KP. Control of methicillin-resistant Staphylococcus aureus bacteraemia in high risk areas. Eur J Clin Microbiol Infect Dis 1994; 13: 82-85.
42. Cafferkey MT. Treatment of invasive MRSA infection. In: Cafferkey MT, Ed. Methicillin-resistant Staphylococcus aureus. Clinical management and laboratory aspects. New York: Marcel Dekker Inc, 1992: 125-147.
43. Williams REO, Jeavons MP, Noble WC et al. Isolation for the control of staphylococcal infection in surgical wards. BMJ 1962; 2: 275-282.
44. Lack CH, Towers AG, Harwood Stevenson F. Cross-infection and its control in an orthopaedic hospital by means of an isolation ward. Lancet 1962; 1: 1228-1232.
45. Turner GC, Watson DC, Abbott JD. An isolation unit for patients with staphylococcal sepsis. Lancet 1965; 2: 426-449.
46. Selkon JB, Stokes ER, Ingram HR. The role of an isolation unit in the control of hospital infection with methicillin-resistant staphylococci. J Hosp Infect 1980; 1: 41-46.
47. Shanson DC, Johnstone D, Midgley J. Control of a hospital outbreak of methicillin-resistant Staphylococcus aureus infections: value of an isolation unit. J Hosp Infect 1985; 6: 285-292.
48. Bradley JM, Noone P, Townsend DE, Grubb WB. Methicillin-resistant Staphylococcus aureus in a London hospital. Lancet 1985; i: 1493-1495.
49. Dacre J, Emmerson AM, Jenner EA. Gentamicin-rnethicillin-resistant Staphylococcus aureus: epidemiology and containment of an outbreak. J Hosp Infect 1986; 7: 130-136.
50. Duckworth GJ, Lothian JLE, Williams JD. Methicillin-resistant Staphylococcus aureus: report of an outbreak in a London teaching hospital, J Hosp Infect 1988; 11: 1-15.
51. Ayliffe GAJ, Babb JR, Taylor L, Wise R. A unit for source and protective isolation in a general hospital. BMJ 1979; 2: 461-465.
52. Ayliffe GAJ, Babb JR, Davies JG, Lilly RA. Hand disinfection: a comparison of various agents in laboratory and ward studies. J Hosp Infect 1988; 11: 226-243.
53. Asensio A, Guerrero A, Quereda C, Lixan M, Martinez-Ferrer M. Colonization and infection with methicillin-resistant Staphylococcus aureus: associated factors and eradication. Infect Control Hosp Epidemiol 1996; 17: 20-28(20).
54. Cookson BD, Emmerson AM, Sedgwick JE, Taylor LJ, Tebbs E. Standards in infection control in hospitals. Report of a combined working party of the Association of Medical Microbiology, Hospital Infection Society, Infection Control Nurses Association and the Public Health Laboratory Service, HMSO, 1993: ISBN 0 901144 36 3.
55. Hospital Infection Control. Guidance on the control of infection in hospitals. Prepared by the Hospital Infection Working Group of the Department of Health and Public Health Laboratory Service 1995.
56. Wilson P, Dunn LJ. Using an MRSA isolation scoring system to decide whether patients should be nursed in isolation. Hyg Med 1996; 21: 465-477.
57. Rahman A, Mackenzie D, Marples R, Cookson BD. Identification of MRSA incidents in hospitals. J Hosp Inf 1995; 30: 76-78.
58. Haley RW, Cushion NB, Tenover FC et al. Eradication of endemic MRSA infections from a neonatal intensive care unit. J Inf Dis 1995; 171: 614-624.
59. Last JM (Ed.). A dictionary of epidemiology. 3rd edn. New York: Oxford University Press, 1995: 112.
60. Sanford MD, Widmer AF, Bale MJ, Jones RN, Wenzel RP. Efficient detection and long-term persistence of the carriage of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 1994; 19: 1123-1128.
61. Rimland D, Roberson B. Gastrointestinal carriage of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 1986; 24: 137-138.
62. Taylor M, Ajayi F, Almond M. Enterocolitis caused by methicillin-resistant Staphylococcus aureus. Lancet 1993; 342: 804.
63. Cookson BD, Phillips I. Methicillin resistant staphylococci. J Appl Bacteriol 1990; 69 (Suppl 19): 55S-70S.
64. Rossi T, Laine J, Eerola E, Kotilainen P, Peltonen R. Denture carriage of methicillin-resistant Staphylococcus aureus. Lancet 1995; 345: 1577.
65. Sherertz RJ, Reagan DR, Hampton KD, BS, Robertson KL, Streed SA, Hoen HM, Thomas R, Gwaltney JM. A cloud adult: The Staphylococcus aureus-virus interaction. Ann. Intern Med 1996; 124: 539-547.
66. Solberg CO. A study of carriers of Staphylococcus aureus. Acta Med Scand 1965; 178 (suppl).
67. Ayliffe GAJ, Babb JR, Collins BJ. Dispersal and skin carriage of staphylococci in healthy male and female subjects and patients with skin disease. In: Hers JFPh, Winkler KC. Eds. Airborne transmission and airborne infection. IV International Symposium on Aerobiology 1973; 435-437.
68. Blowers R, Hill J, Howell A. Shedding of Staph. aureus by human carriers. In: Hers JFPh, Winkler KC. Eds. Airborne transmission and airborne infection. IV International Symposium on Aerobiology 1973; 432-434.
69. Alien KD, Ridgway EJ, Parsons LA. Hexachlorophane powder and neonatal staphylococcal infection. J Hosp Infect 1994; 27: 29-33.
70. Jones EM, Bowker KE, Cooke R et al. Salt tolerance of EMRSA-16 and its effect on the sensitivity of screening cultures. J Hosp Infect 1997; 35: 59-62.
71. Methicillin-resistant Staphylococcus aureus in community settings, Department of Health, 1996 PL(CMO)96.
72. Masterton RG, Coia JE, Notman AW, Kempton-Smith L, Cookson BD. Refractory methicillin-resistant Staphylococcus aureus carriage associated with contamination of the home environment. J Hosp Infect 1995; 29: 318-319.
73. Marples RR, Cooke EM. Current problems with methicillin resistant Staphylococcus aureus. J Hosp Infect 1988; 11: 381-392.
74. Lidwell OM, Polakoff S, Jevons MP et al. Staphylococcal infection in thoracic surgery: experience in a sub-divided ward, J Hyg Camb 1966; 64: 321-337.
75. Cookson BD, Farrington M, Webster M, Phillips J. Methicillin resistant Staphylococcus aureus. Lancet 1985; 2: 218-219.
76. Winn RE, Ward TT, Hartstein AI et al. Epidemiological, bacteriological and clinical observations on an inter-hospital outbreak of nafcillin-resistant Staphylococcus aureus. In: Nelson JD, Grass C, Eds. Current chemotherapy and infectious disease, Vol II. Washington DC: American Society for Microbiology 1989; 1096-1097.
77. Cookson B, Peters B, Webster M et al. Staff carriage of epidemic methicillin-resistant Staphylococcus aureus. J Clin Microbiol 1989; 27: 1471-1476.
78. Hill RLR, Casewell MW. Local treatment of MRSA carriage and colonisation. In: Cafferkey MT, Ed. Methicillin-resistant Staphylococcus aureus. Clinical Management and Laboratory Aspects. New York: Marcel Dekker, Inc. 1992; 149-170.
79. Casewell MW, Hill RLR, Duckworth GJ. The effect of mupirocin on the nasal carriage of Staphylococcus aureus. In: Wilkinson DS, Price JD, Eds. Mupirocin - a novel topical antibiotic for the treatment of skin infection. London. Royal Society of Medicine International Congress and Symposium Series, 80. Royal Society of Medicine 1984; 149-154.
80. Casewell MW, Hill RL. Elimination of nasal carriage of Staphylococcus aureus with mupirocin ('pseudomonic acid') - a controlled trial. J Antimicrob Chemother 1986; 17: 365-372.
81. Hill RLR, Duckworth GJ, Casewell MW. Elimination of nasal carriage of methicillin resistant Staphylococcus aureus with mupirocin during a hospital outbreak. J Antimicrob Chemother 1988; 22: 377-384.
82. Marples RR, Speller DCE, Cookson BD. Prevalence of mupirocin resistance in Staphylococcus aureus. J Hosp Infect 1995; 29: 153-154.
83. Coello R, Fernandez C, Arroyo P et al. Success and failure in the control of methicillin-resistant Staphylococcus aureus. In: Coello R, Casewell MW, Eds. Methicillin-resistant Staphylococcus aureus. Royal Tunbridge Wells: Wells Medical Ltd, 1993: 95-98.
84. Cookson BD. The emergence of mupirocin resistance: a challenge to infection control and antibiotic prescribing practice. J Ant Chemother 1998; 41: 11-18.
85. Sande MA, Mandell GL. Effect of rifampicin on nasal carriage of Staphylococcus aureus. Antimicrob Agents Chemother 1975; 7: 294-297.
86. Dawson SJ, Finn LF, McCulloch JE, Kinington S, Lewis DA. Mupirocin-resistant MRSA. J Hosp Infect 1994; 28: 75-77.
87. Parras F, del Carmen Guerrero M, Bonza E et al. Comparative study of mupirocin and oral co-trimoxazole plus topical fusidic acid in eradication of nasal carriage of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1995; 35: 175-179.
88. Fekety R. Systemic antibiotic treatment of the carrier of methicillin-resistant Staphylococcus aureus. In: Cafferkey MT, Ed. Methicillin-resistant Staphylococcus aureus. Clinical Management and Laboratory Aspects, New York: Marcel Dekker, Inc. 1992; 171-186.
89. Balfour A, Higgins J, Brown M, Gallacher G. Eradication of throat carriage of methicillin-resistant Staphylococcus aureus. J Hosp Infect 1997; 35: 320-321.
90. Davies J, Babb JR, Ayliffe GAJ, Ellis SH. The effect on the skin flora of bathing with antiseptic solutions. J Antimicrob Chemother 1977; 3: 473-481.
91. Shanson DC, McSwiggan DA. Operating theatre acquired infection with a gentamicin-resistant strain of Staphylococcus aureus: out-breaks in two hospitals attributable to one surgeon. J Hosp Infect 1980; 1: 171-172.
92. Bartzokas CA, Paton JH, Gibson MF et al. Control and eradication of methicillin-resistant Staphylococcus aureus on a surgical unit. N Engl J Med 1984; 311: 1422-1425.
93. Haley CE, Marling-Carson M, Smith JW, Luby JP, Mackowiak PA. Bactericidal activity of antiseptics against methicillin-resistant Staphylococcus aureus. J Clin Microbiol 1985; 21: 991-992.
94. Verber IG, Pagan FS. What cord care - if any? Arch Dis Child 1993; 68: 594-596.
95. Alder VG, Burman D, Simpson RA, Fysh J, Gillespie WA et al. Comparison of hexachlorophane and chlorhexidine powders in prevention of neonatal infection. Arch Dis Child 1980; 55: 277-280.
96. Martin-Bowyer G, Labreton R, Toga M, Stolley PD, Lockhart J. Outbreak of accidental hexachlorophene poisoning in France. Lancet 1982; 1: 91-95.
97. Cockburn A, Jackson D, White DJ. The background to the safety and tolerance of mupirocin. In: Dobson RL, Leyden JJ, Noble WC, Proce JD, Eds. Bactroban: Proceedings of an International Symposium, Nassau 1984, London: Excerpta Medica 1985; 11-16.
98. Rahman M, Noble WC, Cookson B. Mupirocin resistant Staphylococcus aureus. Lancet 1987; 2: 387.
99. Baird D, Coia J. Mupirocin-resistant Staphylococcus aureus. Lancet 1987; 2: 387-3888.
100. Carson CF, Cookson BD, Farrelly HD, Riley TV. Susceptibility of methicillin resistant Staphylococcus aureus to the essential oil of Melaleuca alternifolia. J Antimicrob Chemother 1995; 35: 421-424.
101. Medical Devices Agency: Warning 24.11.95
102. Michel M, Gutmann L. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: therapeutic realities and possibilities. Lancet 1997; 349: 1901-06.
103. Fraise A. Guidelines for the control of methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother (in preparation)
104. Cafferkey MT. Treatment of invasive MRSA infection. In: Cafferkey MT, Ed. Methicillin-resistant Staphylococcus aureus. Clinical Management and Laboratory Aspects. New York: Marcel Dekker Inc, 1992, 125-147.
105. Chambers HF. Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications. Clin Microbiol Rev 1997; 10: 781-791.
106. Saunders NJ, Vancomycin administration and monitoring reappraisal. J Antimicrob Chemother 1995; 36: 279-282.
107. Wilson APR, Grüneberg RN, Neu H. Dosage recommendations for teicoplanin. J Antimicrob Chemother 1993; 32: 792-796.
108. Palmer SM, Rybak MJ. An evaluation of the bactericidal activity of ampicillin/sulbactam, piperacillin-tazobactam, imipenem or nafcillin alone and in combination with vancomycin against Methicillin-resistant Staphylococcus aureus (MRSA) in time-kill curves with infected fibrin clots. J Antimicrob Chemother 1997; 39: 515-518.
109. Ramundo MB, Farber BF. Antibiotics available to treat methicillin-resistant Staphylococcus aureus: Pharmacokinetics, toxicity and clinical use. In: Cafferkey MT, Ed. Methicillin-resistant Staphylococcus aureus. Clinical Management and Laboratory Aspects. New York, Marcel Dekker Inc, 1992: 107-124.
110. Markowitz N, Quinn EL, Saravolatz LD. Trimethoprim-sulphamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection. Ann Intern Med 1992; 117: 390-398.
111. Johnson AP, Warner M, Speller DCE. In vitro activity of quinupristin/dalfopristin (Synercid) against isolates of Streptococcus pneumoniae, Staphylococcus aureus and Enterococcus spp. J Antimicrob Chemother 1997; 40: 604-605.
112. Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 1997; 40: 135-136.
113. Livermore D, Warner M, Cookson BD. Detection of vancomycin intermediate resistant Staphylococcus aureus. Eurosurveillance Weekly 1998; 2: Issues 1 and 2 (8.1.98).
114. Noble WC, Virani Z. Cree RGA. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiology Letters 1992; 93: 195-198.
115. Woodford N, Johnson AP, Morrison D, Speller DCE. Current perspectives on glycopeptide resistance. Clin Microbiol Rev 1995; 8: 585-615.
116. Edmond MB, Wenzel RP, Pasculle AW. Vancomycin-resistant Staphylococcus aureus; perspectives on measures needed for control. Ann Intern Med 1996; 124: 329-334.
117. Allen JL, Cowan ME, Cockroft PM. A comparison of three semi-selective media for the isolation of methicillin-resistant Staphylococcus aureus. J Med Microbiol 1995; 40: 98-101.
118. Marples RR, Richardson JF, de Saxe MJ. Bacteriological characters of strains of Staphylococcus aureus submitted to a reference laboratory related to methicillin resistance. J Hyg (Cambridge) 1986; 96; 217-223.
119. Gaston MA, Duff PS, Naidoo J et al. Evaluation of electrophoretic methods for typing methicillin-resistant Staphylococcus aureus. J Med Microbiol 1988; 26, 189-197.
120. Kumari DNP, Keer V, Hawkey PM, Parnell P, Joseph N, Richardson J, Cookson B. Comparisons of ribosome spacer DNA amplicon polymorphisms and pulsed field gel electrophoresis for differentiation of methicillin resistant Staphylococcus aureus strains. J Clin Microbiol 1997; 35: 881-885.
121. Irish D., Eltringham I, Teall A, Pickett H, Farrelly H, Reith S, Woodford N, Cookson B. Control of an outbreak of an epidemic methicillin and mupirocin resistant Staphylococcus aureus. J Hosp Infect (in press).
122. Hookey JV, Richardson JF, Cookson BD. Molecular typing of Staphylococcus aureus based on PCR restriction fragment length polymorphism and DNA sequence analysis of the coagulase gene. J Clin Microbiol 1998; 36: in press
123. McDougal LK, Thornsberry C. The role of beta-lactamase in staphylococcal resistance to penicillinase-resistant penicillins and cephalosporins. J Clin Microbiol 1986; 23: 832-839.
124. Bignardi GE, Woodford N, Chapman A, Johnson AP, Speller DCE. Detection of the mecA gene and phenotypic detection of resistance in Staphylococcus aureus isolates with borderline or low-level methicillin resistance. J Antimicrob Chemother 1996; 37: 53-63.
125. Vannuffel P, Gigi J, Ezzedine H et al. Specific detection of methicillin-resistant Staphylococcus species by multiplex PCR. J Clin Microbiol 1995; 33: 2864-2867.
126. Woodford N, Watson AP, Patel S et al. Heterogeneous location of the mupA high-level mupirocin resistance gene in Staphylococcus aureus. J Med Microbiol (in press).
127. CDC clinical guidelines: MMWR vol. 46/ No. RR-1 Jan. 3 1997. Guidelines for prevention of nosocomial pneumonia.
128. Teare EL, Peacock AJ. In hot pursuit of MRSA. Lancet 1995; 346: 1639.
129. Spicer WJ. Three strategies in the control of staphylococci, including methicillin-resistant Staphylococcus aureus. J Hosp Infect 1984; 5 (suppl): 45-49.
130. Ayliffe G, Cookson BD, Ducel G, Goldmann D, Kereselidze TS, Heuck C-C, Tikhomirov E, Thuriaux MC. World Health Scientific Working Group Report on the Global control of MRSA . WHO, Geneva, Switzerland, 1995 WHO/EMC/LTS/96.1
131. Cookson BD, Webster M, Burnett J, Butler EA, Wright DA. A hospital computer system as a tool for infection control. In: Bryant J, Roberts J, Windsor P, Eds. Current perspectives in health care computing. Weybridge, Surrey: British J Health Care Computing Ltd. 1986; 126-131.
132. Boyce JM, White RL, Causey WA, Lockwood WR. Burn units as a source of methicillin-resistant Staphylococcus aureus infections. JAMA 1983; 249: 2803-2807.
133. Crossley K, Landesman B, Zaske D. An out-break of infections caused by strains of Staphylococcus aureus resistant to methicillin and aminoglycosides. Two epidemiologic studies. J Infect Dis 1979; 139: 280-287.
134. Settle JAD. Infection in burns. J Hosp Infect 1985; 6 (suppl B): 19-29.
135. Ayliffe GAJ, Lawrence JC, Cooke EM et al. Principles of design of burns units: report of a working group. J Hosp Infect 1991; 19: 63-66.